• Cholecystokinin Octapeptide Ammonium in Assays

  2026-09-23

  Practical guidance for using Cholecystokinin octapeptide ammonium (SKU C8717) in viability, apoptosis, and signaling experiments. The article covers concentration planning, solubility and storage constraints, interpretation of cardiac ANP findings, and evidence-based product selection.

• ABT-263 and the Next Logic of Apoptosis Research

  2026-09-23

  ABT-263 (Navitoclax) offers translational researchers more than a Bcl-2 family inhibition tool: it provides a way to connect mitochondrial apoptosis, model selection, assay design, and the emerging complexity of caspase biology.

• Rice 5hmC Maps Reveal Context-Dependent Drought Control

  2026-09-22

  Yan and colleagues established a single-base-resolution view of 5-hydroxymethylcytosine (5hmC) dynamics in rice by integrating ACE-seq with optimized Tn5mC-seq. Their results indicate that drought changes 5hmC in a genomic-context-dependent manner, linking promoter depletion and gene-body accumulation with distinct transcriptional outcomes during stress and recovery.

• Olsalazine Sodium in Cancer Research Workflows

  2026-09-22

  Olsalazine Sodium combines mesalamine dimer chemistry with LTB4-focused anti-inflammatory activity for structured inflammation and colorectal cancer experiments. This guide connects formulation control, apoptosis and proliferation readouts, and transporter-aware exposure measurements into a practical workflow.

• Pretomanid Targets Terminal Oxidases in TB Regimens

  2026-09-21

  This reference study identifies the cytochrome bcc:aa3 and cytochrome bd terminal oxidases as convergent respiratory targets of pretomanid in Mycobacterium tuberculosis. Its genetic and chemical biology evidence supports rational combinations with telacebec and ND-011992 to improve bactericidal activity and limit resistance, particularly in non-replicating populations.

• PAD4-IN-2 TFA: Tumor-Targeted PAD4 Workflows

  2026-09-21

  PAD4-IN-2 TFA, also known as Compound 5i TFA, supports tumor-targeted studies of PAD4, histone H3 citrullination, NET biology, and metastasis. This practical guide connects assay design, immune profiling, handling, and troubleshooting to evidence from preclinical tumor models.

• JXY, TLR4, and Macrophage Polarization in CAC

  2026-09-20

  Liu et al. show that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer in mice while shifting intestinal macrophages toward an M1-like state through TLR4-linked signaling. The study is notable for combining an orthotopic disease model, macrophage phenotyping, functional assays, and pharmacological pathway perturbation, while also identifying questions for mechanistic validation.

• BIBP 3226 Trifluoroacetate in NPY/Y1 Studies

  2026-09-19

  BIBP 3226 trifluoroacetate provides a reversible way to interrogate NPY Y1 and NPFF signaling in cardiac, neuronal, and cAMP assays. Its value is greatest when receptor blockade is paired with coculture models, pathway controls, and careful separation of Y1-driven effects from broader NPFF activity.

• Catalpol Protects Against Triptolide Liver Injury

  2026-09-18

  A 2024 study identifies SIRT1/HIF-1α signaling as a central mechanism by which Catalpol, also known as Catalpinoside in some literature, mitigates triptolide-induced liver injury. By combining metabolomics, Seahorse metabolic profiling, and genetic SIRT1 perturbation, the authors connect hepatic glucose-metabolism disruption, mitochondrial dysfunction, and oxidative stress in a testable mechanistic framework.

• Native Protein Gel Electrophoresis: A Decision Guide

  2026-09-18

  Native protein gel electrophoresis can preserve biologically relevant protein states while separating acidic proteins by charge, shape, and size. This guide explains how to use the K4142 kit as an orthogonal assay within advanced iPSC and CFTR research workflows, including its capabilities and limitations.

• Afatinib in Gastric Cancer Assembloid Research

  2026-09-17

  Afatinib, also known as BIBW 2992, enables mechanism-led interrogation of EGFR, HER2, and HER4 signaling in patient-derived gastric cancer models. This guide translates tumor–stroma assembloid findings into practical dosing, viability, resistance, and troubleshooting workflows.

• TDRD9 siRNA Nanoparticles for P. aeruginosa Lung Injury

  2026-09-17

  A 2026 Nature Communications study identifies TDRD9 as a regulator of neutrophil cuproptosis during Pseudomonas aeruginosa lung infection and develops hyaluronic acid-coated peptide nanoparticles for siRNA delivery. Across patient-derived neutrophils, mouse models, adoptive-transfer experiments, and human lung organoids, TDRD9 silencing reduced neutrophil accumulation, bacterial growth, inflammation, and tissue injury, although clinical translation remains untested.

• EZHIP Mimics H3K27M to Inhibit PRC2

  2026-09-16

  The reference study identifies EZHIP/CXorf67 as an intrinsic PRC2 inhibitor in posterior fossa A ependymoma and defines how its C-terminal peptide mimics the H3K27M oncohistone. The work connects loss of H3K27me3 to aberrant transcriptional activation and provides a mechanistic framework for studying epigenetically driven pediatric brain tumors.

• Ridaforolimus: An Assay-First mTOR Research Guide

  2026-09-16

  Ridaforolimus (Deforolimus) is a potent, selective mTOR inhibitor for dissecting pathway control of proliferation, metabolism, and angiogenesis. This assay-first guide connects its pharmacology with machine-learning-guided senolytic research while showing how to distinguish pathway engagement, apoptosis, senescence, and selective cell killing.

• CP-673451: Selective PDGFRα/β Workflow Guide

  2026-09-15

  CP-673451 provides a focused way to interrogate PDGFRα/β signaling, phosphorylation, angiogenesis, and tumor phenotypes without the broad kinase activity of many multikinase inhibitors. This practical guide connects concentration design, ATRX-aware glioma experiments, angiogenesis assays, and xenograft readouts into a reproducible cancer research workflow.

8458 records 1/564 page Next 12345 下5页 Last page